Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study
Background. WHO clinical staging has long been used to assess the immunological status of HIV-infected patients at initiation of antiretroviral therapy and during treatment follow-up. In setups where CD4 count determination is not readily available, WHO clinical staging is a viable option. However,...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | AIDS Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2020/2163486 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559252126826496 |
|---|---|
| author | Abraham Desta Aregay Kibriti Mehari Kidane Asfawosen Berhe Aregay Kiros Ajemu Fenta Ataklti Gebretsadik Woldegebriel Hagos Godefay Tewolde Wubayehu Woldearegay |
| author_facet | Abraham Desta Aregay Kibriti Mehari Kidane Asfawosen Berhe Aregay Kiros Ajemu Fenta Ataklti Gebretsadik Woldegebriel Hagos Godefay Tewolde Wubayehu Woldearegay |
| author_sort | Abraham Desta Aregay |
| collection | DOAJ |
| description | Background. WHO clinical staging has long been used to assess the immunological status of HIV-infected patients at initiation of antiretroviral therapy and during treatment follow-up. In setups where CD4 count determination is not readily available, WHO clinical staging is a viable option. However, correlation between CD4 count and WHO clinical staging is not known in an Ethiopian setting, and hence, the main aim of this study was to assess predictability of CD4 T-lymphocyte count using WHO clinical staging among ART-naïve HIV-infected adolescents and adults in northern Ethiopia. Methods. A retrospective cross-sectional study was done in the Tigray Region, Ethiopia, from April 2015 to January 2019 from a secondary database of 19525 HIV-infected patients on antiretroviral treatment. Analysis was done using STATA-14.0 to estimate the frequencies, mean, and median of CD4 T-cell count in each WHO stages. Sensitivity, specificity, positive predictive value, negative predictive value, kappa test, and correlations were calculated to show the relationships between WHO stages and CD T-cell count. Results. The sensitivity of WHO clinical staging to predict CD4 T-cell counts of <200 cells/μl was 94.17% with a specificity of 3.62%. The PPV was 49.03%, and the NPV was 3.62%. The sensitivity of WHO clinical staging to predict CD4 T-cell counts of <350 cells/μl was 94.75% with a specificity of 3.00%. The PPV was 75.81%, and the NPV was 15.09%. Similarly, the sensitivity of WHO clinical staging to predict CD4 T-cell counts of <500 cells/μl was 95.03% with a specificity of 2.73% and the PPV and NPV were 88.32% and 6.62%, respectively. The kappa agreement of WHO clinical stages was also insignificant when compared with the disaggregated CD4 counts in different categories. The correlation of WHO clinical staging was inversely associated with the CD4 count, and the magnitude of the correlation was 5.22%. Conclusions. The WHO clinical staging had high sensitivity but low specificity in predicting patients with CD4 count <200 cells/μl, <350 cells/μl, and <500 cells/μl. There was poor correlation and agreement between CD4 T-lymphocyte count and WHO clinical staging. Therefore, WHO clinical staging alone may not provide accurate information on the immunological status of patients, and hence, it is better to use the CDC definition rather than the WHO clinical definition. |
| format | Article |
| id | doaj-art-ef830f63544f44178997ec704c991542 |
| institution | Kabale University |
| issn | 2090-1240 2090-1259 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | AIDS Research and Treatment |
| spelling | doaj-art-ef830f63544f44178997ec704c9915422025-02-03T01:30:31ZengWileyAIDS Research and Treatment2090-12402090-12592020-01-01202010.1155/2020/21634862163486Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective StudyAbraham Desta Aregay0Kibriti Mehari Kidane1Asfawosen Berhe Aregay2Kiros Ajemu Fenta3Ataklti Gebretsadik Woldegebriel4Hagos Godefay5Tewolde Wubayehu Woldearegay6Tigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Regional Health Bureau, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaBackground. WHO clinical staging has long been used to assess the immunological status of HIV-infected patients at initiation of antiretroviral therapy and during treatment follow-up. In setups where CD4 count determination is not readily available, WHO clinical staging is a viable option. However, correlation between CD4 count and WHO clinical staging is not known in an Ethiopian setting, and hence, the main aim of this study was to assess predictability of CD4 T-lymphocyte count using WHO clinical staging among ART-naïve HIV-infected adolescents and adults in northern Ethiopia. Methods. A retrospective cross-sectional study was done in the Tigray Region, Ethiopia, from April 2015 to January 2019 from a secondary database of 19525 HIV-infected patients on antiretroviral treatment. Analysis was done using STATA-14.0 to estimate the frequencies, mean, and median of CD4 T-cell count in each WHO stages. Sensitivity, specificity, positive predictive value, negative predictive value, kappa test, and correlations were calculated to show the relationships between WHO stages and CD T-cell count. Results. The sensitivity of WHO clinical staging to predict CD4 T-cell counts of <200 cells/μl was 94.17% with a specificity of 3.62%. The PPV was 49.03%, and the NPV was 3.62%. The sensitivity of WHO clinical staging to predict CD4 T-cell counts of <350 cells/μl was 94.75% with a specificity of 3.00%. The PPV was 75.81%, and the NPV was 15.09%. Similarly, the sensitivity of WHO clinical staging to predict CD4 T-cell counts of <500 cells/μl was 95.03% with a specificity of 2.73% and the PPV and NPV were 88.32% and 6.62%, respectively. The kappa agreement of WHO clinical stages was also insignificant when compared with the disaggregated CD4 counts in different categories. The correlation of WHO clinical staging was inversely associated with the CD4 count, and the magnitude of the correlation was 5.22%. Conclusions. The WHO clinical staging had high sensitivity but low specificity in predicting patients with CD4 count <200 cells/μl, <350 cells/μl, and <500 cells/μl. There was poor correlation and agreement between CD4 T-lymphocyte count and WHO clinical staging. Therefore, WHO clinical staging alone may not provide accurate information on the immunological status of patients, and hence, it is better to use the CDC definition rather than the WHO clinical definition.http://dx.doi.org/10.1155/2020/2163486 |
| spellingShingle | Abraham Desta Aregay Kibriti Mehari Kidane Asfawosen Berhe Aregay Kiros Ajemu Fenta Ataklti Gebretsadik Woldegebriel Hagos Godefay Tewolde Wubayehu Woldearegay Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study AIDS Research and Treatment |
| title | Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study |
| title_full | Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study |
| title_fullStr | Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study |
| title_full_unstemmed | Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study |
| title_short | Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study |
| title_sort | prediction of cd4 t lymphocyte count using who clinical staging among art naive hiv infected adolescents and adults in northern ethiopia a retrospective study |
| url | http://dx.doi.org/10.1155/2020/2163486 |
| work_keys_str_mv | AT abrahamdestaaregay predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy AT kibritimeharikidane predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy AT asfawosenberhearegay predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy AT kirosajemufenta predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy AT atakltigebretsadikwoldegebriel predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy AT hagosgodefay predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy AT tewoldewubayehuwoldearegay predictionofcd4tlymphocytecountusingwhoclinicalstagingamongartnaivehivinfectedadolescentsandadultsinnorthernethiopiaaretrospectivestudy |